Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-04-09
2000-06-20
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514324, 514325, 514443, 514444, 514445, 514878, 514879, A01N 4340
Patent
active
060778520
ABSTRACT:
The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of the formula ##STR1## in which R.sup.1 and R.sup.2 are independently hydroxy and alkoxy of one to four carbon atoms; and R.sup.3 and R.sup.4 are independently methyl or ethyl, or R.sup.3 and R.sup.4, taken together with the nitrogen atom to which they are attached, form a pyrrolidino, methyl-pyrrolidino, dimethylpyrrolidino, piperidino, morpholino, or hexamethyleneimino ring.
REFERENCES:
patent: 3293263 (1966-12-01), Lednicer
patent: 3320271 (1967-05-01), Lednicer
patent: 3394125 (1968-07-01), Crenshaw
patent: 3413305 (1968-11-01), Crenshaw
patent: 3862232 (1975-01-01), Lednicer
patent: 4117128 (1978-09-01), Brenner
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 4910212 (1990-03-01), Boyle et al.
patent: 5013761 (1991-05-01), Beedle et al.
patent: 5223510 (1993-06-01), Gubin et al.
patent: 5254568 (1993-10-01), Kapil et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5389670 (1995-02-01), Fontana
patent: 5434166 (1995-07-01), Glasebrook
patent: 5439931 (1995-08-01), Sales
patent: 5462950 (1995-10-01), Fontana
patent: 5470854 (1995-11-01), von Angerer et al.
patent: 5488058 (1996-01-01), Palkowitz
patent: 5492922 (1996-02-01), Palkowitz
patent: 5508292 (1996-04-01), Sall et al.
patent: 5510357 (1996-04-01), Palkowitz
patent: 5510358 (1996-04-01), Palkowitz
patent: 5510498 (1996-04-01), Palkowitz
patent: 5512296 (1996-04-01), Cullinan
patent: 5534526 (1996-07-01), Cullinan
patent: 5550150 (1996-08-01), Fontana
patent: 5552415 (1996-09-01), May
patent: 5574190 (1996-11-01), Palkowitz
patent: 5576337 (1996-11-01), Bruns, Jr. et al.
patent: 5578613 (1996-11-01), Bryant et al.
patent: 5578614 (1996-11-01), Bryant et al.
patent: 5663184 (1997-09-01), Bryant et al.
patent: 5686476 (1997-11-01), May
patent: 5723474 (1998-03-01), Palkowitz
patent: 5731342 (1998-03-01), Cullinan et al.
Fisher et al., J. National Cancer Institute, 86:527-537 (1994).
Cummings, et al., JAMA, 281:2189-2197 (1999).
Palkowitz, et al., J. Med. Chemistry, 40: 1407-1416 (1997).
"Women on Estrogen Appear at Less Risk of Alzheimer's", Indianapolis, Star, Nov. 10, 1993.
"New Alzheimer's Therapy Suggested", Science, 260, 1719-1720 (Jun. 18, 1993).
Crenshaw, R. R., et al., J. Med. Chem., 14 (12) :1185-1190 (1971).
Durani, N., et al., Indian J. Chem., 22B:489-490 (1983).
Jones, C. D., et al., J. Med. Chem., 35:931-938 (1992).
Lednicer, D., et al., J. Med. Chem., 8:52-57 (1964).
Jones, et al., J. Med. Chem., 27:1057-66 (1984).
Madesclaire, M., Tetrahedren, 42 (20) :5459-5495 (1986).
Trost, B. M., et al., Tetrahedren Letters, 22 (14) :1287-1290.
Drabowicz, J., et al., Synthetic Communications, 11 (12) :1025-1030 (1981).
Kramer, J. B., et al., 34.sup.th National Organic Symposium, Williamsburg, VA. (Jun. 11-15, 1995).
Wyngaarden, et al., Cecil Textbook of Medicine, 16:1271 (1983).
Bales Kelly Renee
Bryant Henry Uhlman
Knadler Mary Patricia
Paul Steven Marc
Boudreaux William R.
Eli Lilly and Company
Krass Frederick
LandOfFree
Treatment of central nervous system disorders with selective est does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of central nervous system disorders with selective est, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of central nervous system disorders with selective est will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853925